Osteoarthritis (OA) is the most common cause of disability worldwide among the elderly.
Alarmingly, the incidence of OA in individuals less than 40 years of age is rising, likely due to …

Osteoarthritis (OA) is a common age-related disease that correlates with a high number of
senescent cells in joint tissues. Senescence has been reported to be one of the main drivers …

Osteoarthritis (OA) has been recognized as an age-related degenerative disease commonly
seen in the elderly that affects the whole “organ” including cartilage, subchondral bone …

The development of osteoarthritis (OA) correlates with a rise in the number of senescent
cells in joint tissues, and the senescence-associated secretory phenotype (SASP) has been …

Osteoarthritis (OA), a chronic joint disease affecting millions of people aged over 65 years, is
the main musculoskeletal cause of diminished joint mobility in the elderly. It is characterized …

Cellular senescence is associated with normal development and wound healing, but has
also been implicated in the pathogenesis of numerous aging-related diseases including …

Simple Summary Although mesenchymal stem cells (MSCs) have demonstrated their
therapeutic potential for osteoarthritis (OA) treatment in preclinical and clinical studies …

Osteoarthritis (OA) is an inflammatory condition still lacking effective treatments.
Mesenchymal stem/stromal cells (MSCs) have been successfully employed in pre-clinical …

Osteoarthritis (OA) is a degenerative joint condition that contributes to years lived with
disability. Current therapeutic approaches are limited as there are no disease-modifying …

Osteoarthritis (OA) affects all articular tissues leading to pain and disability. The
dysregulation of bone metabolism may contribute to the progression of this condition …